Comparison of Responses of Human Melanoma Cell Lines to MEK and BRAF Inhibitors

Frontiers in Genetics - Switzerland
doi 10.3389/fgene.2013.00066
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

Inhibitors of Pan-Pi3k Signaling Synergize With BRAF or MEK Inhibitors to Prevent BRAF-Mutant Melanoma Cell Growth

Frontiers in Oncology
Cancer ResearchOncology
2015English

PAK Signaling Promotes Acquired Resistance to BRAF and MEK Inhibitors

Cancer Discovery
Oncology
2017English

Combination Therapy With BRAF and MEK Inhibitors for Melanoma: Latest Evidence and Place in Therapy

Therapeutic Advances in Medical Oncology
Oncology
2015English

Efficacy, Safety, and Tolerability of Approved Combination BRAF and MEK Inhibitor Regimens for BRAF-Mutant Melanoma

Cancers
Cancer ResearchOncology
2019English

Antitumor Effects of the Investigational Selective MEK Inhibitor TAK733 Against Cutaneous and Uveal Melanoma Cell Lines

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2012English

BRAF,NRASandKITsequencing Analysis of Spindle Cell Melanoma

Journal of Cutaneous Pathology
DermatologyForensic MedicinePathologyHistology
2012English

AurkA Inhibitors Enhance the Effects of B-Raf and MEK Inhibitors in Melanoma Treatment

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2015English

Anaplastic Lymphoma Kinase Confers Resistance to BRAF Kinase Inhibitors in Melanoma

iScience
Multidisciplinary
2019English

Clinical Outcomes of BRAF Plus MEK Inhibition in Melanoma: A Meta‐analysis and Systematic Review

Cancer Medicine
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy